Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling
R. P. Tripathi(University of Kentucky), Rina Plattner(University of Kentucky), Christina Meeks(University of Kentucky), Andrey Rymar(Plexxikon (United States)), Anastasia Lyon(University of Kentucky), Aditi Jain(Indian Institute of Science Bangalore), Dana Richards(University of Kentucky), Marika Nespi(Plexxikon (United States)), Daheng He(University of Kentucky), Peng Wang(Shanghai Medical College of Fudan University), Jinpeng Liu(University of Kentucky), Melissa Wilson(Massachusetts Institute of Technology), Chi Wang(University of Kentucky), Zulong Liu(University of Kentucky)
Cited by 51
Related Papers
Role of experience and oscillations in transforming a rate code into a temporal code
|Nature|2002|657
c-Abl is activated by growth factors and Src family kinases and has a role in the cellular response to PDGF
|Genes & Development|1999|426
Extracellular Vesicles Long RNA Sequencing Reveals Abundant mRNA, circRNA, and lncRNA in Human Blood as Potential Biomarkers for Cancer Diagnosis
|Clinical Chemistry|2019|283
Activation of Abl Tyrosine Kinases Promotes Invasion of Aggressive Breast Cancer Cells
|Cancer Research|2006|199